Legato Capital Management LLC Ligand Pharmaceuticals Inc Transaction History
Legato Capital Management LLC
- $761 Million
- Q3 2024
A detailed history of Legato Capital Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Legato Capital Management LLC holds 17,305 shares of LGND stock, worth $1.96 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
17,305
Previous 14,120
22.56%
Holding current value
$1.96 Million
Previous $1.19 Million
45.75%
% of portfolio
0.23%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding LGND
# of Institutions
256Shares Held
18.1MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$326 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$223 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$114 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$101 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$80.2 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.91B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...